SCLP Share PerformanceMore

52 week high47.000 09/12/13
52 week low23.930 15/11/13
52 week change -5.750 (-15.33%)
4 week volume3,385,304 24/08/14

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Notice of AGM

Notification of a company’s annual general meeting

Presenting at Upcoming Scientific Conferences

Higher losses at Scancell Holdings

Scancell Holdings, the developer of novel immunotherapies for the treatment of cancer, has announced a loss of 2,222,954 ...

Final Results

Announcement of full year/4th quarter financial results

Scancell Holdings - Synergy of SCIB1 with checkpoint inhibitors

Synergy of SCIB1 with checkpoint inhibitors

Miscellaneous medium priority announcements

Director/PDMR Shareholding

Notification of issuers, persons discharging managerial responsibilities and their connected persons in respect of transactions conducted in their own account in shares of the issuer

Scancell Holdings - SCIB1 Phase 1/2 clinical trial results presented at ASCO and DNA ImmunoBody patent granted in United States